Outcomes for Patients with Classical Hodgkin Lymphoma Who Relapse after Autologous Stem Cell Transplant in the Era of Novel Therapies

被引：0
|
作者：
Stuver, Robert [1 ]
Drill, Esther [2 ]
Ganesan, Nivetha [1 ]
Baron, Kelsey [3 ]
Casper, Ellie [1 ]
Chang, Tiffany [1 ]
Desai, Sanjal H. [4 ]
Falade, Ayo S. [5 ]
Galasso, Natasha [1 ]
Herrera, Alex F. [6 ]
Mei, Matthew G. [7 ]
Merryman, Reid W. [5 ]
Micallef, Ivana [8 ]
Shah, Harsh [9 ]
Moskowitz, Alison [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY USA
[3] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
[4] Univ Minnesota, St Paul, MN USA
[5] Dana Farber Canc Inst, Boston, MA USA
[6] City Hope Natl Med Ctr, Duarte, CA USA
[7] City Hope Natl Med Ctr, Duarte, CA USA
[8] Mayo Clin, Rochester, MN USA
[9] Univ Utah, Salt Lake City, UT USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-182143
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Defining a Hodgkin lymphoma population for novel therapeutics after relapse from autologous hematopoietic cell transplant
    Arai, Sally
    Fanale, Michelle
    deVos, Sven
    Engert, Andreas
    Illidge, Tim
    Borchmann, Peter
    Younes, Anas
    Morschhauser, Franck
    McMillan, Alex
    Horning, Sandra J.
    LEUKEMIA & LYMPHOMA, 2013, 54 (11) : 2531 - 2533
  • [22] Analysis of Relapse Biopsies in Classical Hodgkin Lymphoma Reveals Correlations with Outcome after Autologous Stem Cell Transplantation
    Chan, Fong Chun
    Mottok, Anja
    Gerrie, Alina S.
    Power, Maryse M.
    Savage, Kerry J.
    Connors, Joseph M.
    Gascoyne, Randy D.
    Shah, Sohrab P.
    Scott, David W.
    Steidl, Christian
    BLOOD, 2014, 124 (21)
  • [23] Correction: The outcome of patients with Hodgkin lymphoma and early relapse after autologous stem cell transplant has improved in recent years
    Ali Bazarbachi
    Ariane Boumendil
    Hervé Finel
    Irma Khvedelidze
    Joanna Romejko-Jarosinska
    Alina Tanase
    Saad Akhtar
    Tarek Ben Othman
    Mohammad Ma’koseh
    Boris Afanasyev
    Jean El-Cheikh
    Javier Briones
    Zafer Gülbas
    Rose-Marie Hamladji
    Tugrul Elverdi
    Didier Blaise
    Carmen Martínez
    Eleonora Alma
    Kazimierz Halaburda
    Aida Botelho Sousa
    Bertram Glass
    Steven Robinson
    Silvia Montoto
    Anna Sureda
    Leukemia, 2022, 36 : 2150 - 2150
  • [24] Brentuximab Vedotin for Relapse After Autologous Stem Cell Transplant in Patients With Hodgkin Lymphoma. A Study of the LWP-EBMT
    Chavda, Nikesh
    Robinson, Stephen
    Boumendil, Ariane
    Khvedelidze, Irma
    Finel, Herve
    Akhtar, Saad
    Rauf, Muhammad Shahzad
    Durakovic, Nadira
    Vrhovac, Radovan
    Musso, Maurizio
    Brice, Pauline
    Arat, Mutlu
    Blaise, Didier
    Collin, Matthew
    Romejko-Jarosinska, Joanna
    Stamatoullas, Aspasia
    Ozkurt, Zubeyde Nur
    Robak, Tadeusz
    Wahlin, Bjorn
    Wilson, Keith M. O.
    Alma, Eleonora
    Pastano, Rocco
    Castagna, Luca
    Bazarbachi, Ali
    Ghesquieres, Herve
    Colita, Andrei
    Montoto, Silvia
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 116 - 117
  • [25] Positive impact of brentuximab vedotin on overall survival of patients with classical Hodgkin lymphoma who relapse or progress after autologous stem cell transplantation: A nationwide analysis
    Tsirigotis, Panagiotis
    Vassilakopoulos, Theodoros
    Batsis, Ioannis
    Bousiou, Zoi
    Gkirkas, Konstantinos
    Sakellari, Ioanna
    Kaloyannidis, Panayotis
    Roussou, Paraskevi
    Pangalis, Gerassimos A.
    Moschogiannis, Maria
    Vassilopoulos, George
    Repousis, Panagiotis
    Megalakaki, Aekaterini
    Michalis, Eurydiki
    Kalpadakis, Christina
    Papadaki, Helen A.
    Kotsianidis, Ioannis
    Hatzimichael, Eleftheria
    Spyridonidis, Alexandros
    Anargyrou, Konstantinos
    Poulakidas, Elias
    Giannoullia, Panagiota
    Apostolidis, Ioannis
    Stamouli, Maria
    Konstantopoulos, Konstantinos
    Pappa, Vassiliki
    Panayiotidis, Panayiotis
    Harhalakis, Nikolaos
    Anagnostopoulos, Achilles
    Angelopoulou, Maria
    HEMATOLOGICAL ONCOLOGY, 2018, 36 (04) : 645 - 650
  • [26] Therapeutic options for patients with Hodgkin's disease and non-Hodgkin's lymphoma who relapse after autologous transplant
    van Besien K.
    Smith S.
    Lazarus H.M.
    Current Treatment Options in Oncology, 2005, 6 (4) : 279 - 287
  • [27] The role of autologous stem-cell transplantation in classical Hodgkin lymphoma in the modern era
    Varma, Gaurav
    Diefenbach, Catherine
    SEMINARS IN HEMATOLOGY, 2024, 61 (04) : 253 - 262
  • [28] Outcomes of Hodgkin's lymphoma patients with relapse or progression following first autologous stem cell transplantation
    Kaloyannidis, P.
    Voudiadou, G.
    Balta, A.
    Spyridonidis, A.
    Tsimperis, S.
    Baltadakis, I.
    Symeonidis, A.
    Apostolidis, J.
    Smias, C.
    Karakasis, D.
    Sakellari, I.
    Zoumpos, N.
    Harhalakis, N.
    Anagnostopoulos, A.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S252 - S252
  • [29] Lymphocyte Recovery Following Autologous Hematopoietic Stem Cell Transplant in Classical Hodgkin Lymphoma
    Rose, Ashley
    Gesiotto, Quinto J.
    Isenalumhe, Leidy
    Khimani, Farhad
    Liu, Hien D.
    Gaballa, Sameh
    Chavez, Julio C.
    Shah, Bijal D.
    Ibarz, Javier Pinilla
    Bello, Celeste
    Sokol, Lubomir
    Saeed, Hayder
    BLOOD, 2021, 138
  • [30] TREATMENTS AND CLINICAL BURDEN AMONG HODGKIN LYMPHOMA PATIENTS AT HIGH RISK OF RELAPSE AFTER AUTOLOGOUS STEM CELL TRANSPLANT: A LITERATURE REVIEW
    Bonthapally, V.
    Ayyagari, R.
    Yang, H.
    Wu, E. Q.
    Shonukan, O.
    HAEMATOLOGICA, 2014, 99 : 677 - 677
12345